You are registering to attend the online Cancer: Pathophysiology, Current Therapies, Clinical Trials, and Drug Development on October 22 – 24, 2025.
Course Description:
Therapeutics for cancer are entering a new era, where precision approaches promise to revolutionize the way in this disease is treated. This comprehensive course reviews current and emerging drugs, immunotherapies, their application to specific cancer types, how to conduct clinical trials for oncologic therapies, and the drug development process for drug candidates leading to their approval. The US Food & and Drug Administration (FDA) regulatory considerations for oncology drugs, registration endpoints, and accelerated and breakthrough approval mechanisms are also covered.
Course Prices:
Individual Course Registration: $1,795.00 USD
Early Individual Course Registration: $1,595.00 USD
Please allow up to 24 hours to receive your official course registration confirmation.
Early Bird Registration ends Friday, September 12, 2025.
-
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development
October 22, 2025 - October 24, 2025
10:00 am - 4:00 pm